Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation

被引：28

作者：

Van Bömmel, F ^{[1
]}

Schernick, A ^{[1
]}

Hopf, U ^{[1
]}

Berg, T ^{[1
]}

机构：

[1] Humboldt Univ, Charite, Med Klin Scherpunkt Hepatol & Gastroenterol, Berlin, Germany

来源：

GASTROENTEROLOGY | 2003年 / 124卷 / 02期

关键词：

D O I：

10.1053/gast.2003.1240586b

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：586 / 587

页数：2

共 9 条

[1]

Benhamou Y, 2002, J HEPATOL, V36, P138

[2] Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV [J].

Bonacini, M ;

Kurz, A ;

Locarnini, S ;

Ayres, A ;

Gibbs, C .

GASTROENTEROLOGY, 2002, 122 (01) :244-245

[3] Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors [J].

Cihlar, T ;

Birkus, G ;

Greenwalt, DE ;

Hitchcock, MJM .

ANTIVIRAL RESEARCH, 2002, 54 (01) :37-45

[4]

JAMES JS, 2001, AIDS TREAT NEWS, V26, P2

[5] Management of hepatitis B: 2000 - Summary of a workshop [J].

Lok, AS ;

Heathcote, EJ ;

Hoofnagle, JH .

GASTROENTEROLOGY, 2001, 120 (07) :1828-1853

[6] Adefovir dipivoxil (ADV) alone and in combination with lamivudine (LAM) suppresses LAM-resistant hepatitis B virus (HBV) replication: 16 week interim analysis [J].

Peters, M ;

Hann, HW ;

Martin, P ;

Heathcote, E ;

Buggisch, P ;

Moorat, AE ;

Sullivan, M ;

Kleber, K ;

Ebrahimi, R ;

Xiong, S ;

Brosgart, C .

JOURNAL OF HEPATOLOGY, 2002, 36 :6-7

[7] Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region [J].

Stuyver, LJ ;

Locarnini, SA ;

Lok, A ;

Richman, DD ;

Carman, WF ;

Dienstag, JL ;

Schinazi, RF .

HEPATOLOGY, 2001, 33 (03) :751-757

[8]

VANBOMMEL F, 2002, IN PRESS HEPATOLOGY, P35

[9]

Ying C, 2000, J VIRAL HEPATITIS, V7, P161

← 1 →